documents: FDA-2023-N-2177-0087

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2023-N-2177-0087 FDA FDA-2023-N-2177 Reference 44 - Letter from D. Bruce Burlington M.D. Director FDA-CDRH to Jeffrey N. Gibbs Esq. Hyman Phelps McNamara P.C. RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:03:05Z   0 0 09000064860259dd

Links from other tables